Skip to main content

Tripos Discovery Informatics Names New CEO

NEW YORK (GenomeWeb News) – Tripos Discovery Informatics has tapped Jim Hopkins to be CEO of the newly private company, which was purchased last week by Vector Capital for $26.2 million.
 
Hopkins most recently was CEO of the software company Micrografx, now owned by Corel. He is experienced in IPOs, secondary offerings, and in strategic sales and acquisitions, the company said. 
 
Hopkins said he is “excited to lead this organization as an independent company, refocused and poised for profitable growth.”
 
Tripos said it plans to focus on innovating its core technologies, specifically its SYBYL suite, which supports drug-discovery workflows.
The Scan

And For Adolescents

The US Food and Drug Administration has authorized the Pfizer-BioNTech SARS-CoV-2 vaccine for children between the ages of 12 and 15 years old.

Also of Concern to WHO

The Wall Street Journal reports that the World Health Organization has classified the SARS-CoV-2 variant B.1.617 as a "variant of concern."

Test for Them All

The New York Times reports on the development of combined tests for SARS-CoV-2 and other viruses like influenza.

PNAS Papers on Oral Microbiome Evolution, Snake Toxins, Transcription Factor Binding

In PNAS this week: evolution of oral microbiomes among hominids, comparative genomic analysis of snake toxins, and more.